Simplex Trading’s BioCardia BCDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-480
Closed -$2K 8774
2024
Q1
$2K Buy
+480
New +$3.44K ﹤0.01% 8359
2023
Q3
Sell
-240
Closed -$4.04K 8660
2023
Q2
$9K Buy
+240
New +$7.4K ﹤0.01% 7469
2023
Q1
Sell
-503
Closed -$16.7K 9007
2022
Q4
$15K Buy
503
+116
+30% +$3.3K ﹤0.01% 7124
2022
Q3
$11K Buy
387
+236
+156% +$6.1K ﹤0.01% 8122
2022
Q2
$3K Sell
151
-39
-21% -$934 ﹤0.01% 9109
2022
Q1
$5K Sell
190
-527
-74% -$15.7K ﹤0.01% 9386
2021
Q4
$20K Buy
717
+426
+146% +$15.6K ﹤0.01% 8344
2021
Q3
$17K Hold
291
﹤0.01% 8555
2021
Q2
$17K Sell
291
-1,252
-81% -$76K ﹤0.01% 8704
2021
Q1
$100K Buy
+1,543
New +$96.4K ﹤0.01% 5743

Other funds holding BCDA

Simplex Trading's BCDA Position: Q2 2024 in Review

Simplex Trading sold out of BioCardia (BCDA) in Q2 2024, closing a stake of 480 shares — an estimated $2K sold.

Simplex Trading first reported a position in BCDA in Q1 2021 and held it in 10 quarters. The position peaked at $100K in Q1 2021. 10 funds tracked by Wall St. Rank hold BCDA as of Q2 2024.

  • Simplex Trading reported no remaining BioCardia position as of Q2 2024 after selling out during the quarter.
  • Simplex Trading sold 480 BioCardia shares in Q2 2024, an estimated $2K.
  • Simplex Trading first reported a position in BioCardia in Q1 2021 and held it in 10 quarters.
  • Simplex Trading's BioCardia position peaked at $100K in Q1 2021.
  • 10 funds tracked by Wall St. Rank held BioCardia as of Q2 2024.

Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.